Abstract
Objective
Tumor necrosis factor-β (TNF-β) plays important roles in mediating cancer development. Many studies have argued possible associations of TNF-β +252 A>G polymorphism with different cancers. However, association between this most frequently studied polymorphism and susceptibility to cancer still remains controversial and ambiguous. The aim of this study is to determine the relationship of TNF-β +252 A>G polymorphism with cancer through meta-analysis.
Methods
Electronic searches of several databases were conducted for all publications on the associations between this variant and cancer through October 2011. Odds ratios (ORs) with 95 % confidence intervals (95 % CIs) were used to access the strength of this association in random-effect model.
Results
Thirty-three studies with 14,435 cancer patients and 10,583 healthy controls were included. In this meta-analysis, we detected statistically significant connections between this polymorphism and cancer risks [GG + GA vs. AA: OR = 1.24, 95 % CI = 1.02–1.51; GG vs. AA: OR = 1.43, 95 % CI = 1.05–1.95; G vs. A: OR = 1.28, 95 % CI = 1.28 (1.09–1.50)] in the overall ethnic population. Meanwhile, we detected significant associations in Asian population (GG + GA vs. AA), other population (GG vs. GA + AA), and Caucasian population (GG vs. AA, G vs. A) with the OR values being 1.21 (1.04–1.40), 1.64 (1.35–1.99), 1.65 (1.02, 2.65), and 1.39 (1.09–1.75), respectively.
Conclusions
TNF-β +252 A>G polymorphism is positively associated with susceptibility to cancer. However, this study also suggests that more studies should be conducted to further confirm the associations between this variant and specific types of cancers.
Similar content being viewed by others
References
Cerhan JR, Liu-Mares W, Fredericksen ZS, Novak AJ, Cunningham JM, Kay NE, Dogan A, Liebow M, Wang AH, Call TG, Habermann TM, Ansell SM, Slager SL (2008) Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin’s lymphoma. Cancer Epidemiol Biomarkers Prev 17(11):3161–3169
Chandru H, Boggaram V (2007) The role of sphingosine 1-phosphate in the TNF-alpha induction of IL-8 gene expression in lung epithelial cells. Gene 391(1–2):150–160
Crusius JB, Canzian F, Capella G, Pena AS, Pera G, Sala N, Agudo A, Rico F, Del Giudice G, Palli D, Plebani M, Boeing H, Bueno-de-Mesquita HB, Carneiro F, Pala V, Save VE, Vineis P, Tumino R, Panico S, Berglund G, Manjer J, Stenling R, Hallmans G, Martinez C, Dorronsoro M, Barricarte A, Navarro C, Quiros JR, Allen N, Key TJ, Binghan S, Caldas C, Linseisen J, Kaaks R, Overvad K, Tjonneland A, Buchner FC, Peeters PH, Numans ME, Clavel-Chapelon F, Trichopoulou A, Lund E, Jenab M, Rinaldi S, Ferrari P, Riboli E, Gonzalez CA (2008) Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol 19(11):1894–1902
de Oliveira JP, Fernandes F, Cruz AK, Trombela V, Monteiro E, Camargo AA, Barral A, de Oliveira CI (2007) Genetic diversity of Leishmania amazonensis strains isolated in northeastern Brazil as revealed by DNA sequencing, PCR-based analyses and molecular karyotyping. Kinetoplastid Biol Dis 6:5
Ennas MG, Moore PS, Zucca M, Angelucci E, Cabras MG, Melis M, Gabbas A, Serpe R, Madeddu C, Scarpa A, Cocco P (2008) Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia. Hematol Oncol 26(2):98–103
Garcia-Gonzalez MA, Lanas A, Quintero E, Nicolas D, Parra-Blanco A, Strunk M, Benito R, Angel Simon M, Santolaria S, Sopena F, Piazuelo E, Jimenez P, Pascual C, Mas E, Irun P, Espinel J, Campo R, Manzano M, Geijo F, Pellise M, Gonzalez-Huix F, Nieto M, Espinos J, Tito L, Bujanda L, Zaballa M (2007) Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: a Nationwide Multicenter Study in Spain. Am J Gastroenterol 102(9):1878–1892
Gaudet MM, Egan KM, Lissowska J, Newcomb PA, Brinton LA, Titus-Ernstoff L, Yeager M, Chanock S, Welch R, Peplonska B, Trentham-Dietz A, Garcia-Closas M (2007) Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF–LTA) and breast cancer risk. Hum Genet 121(3–4):483–490
Guo W, Wang N, Li Y, Zhang JH (2005) Polymorphisms in tumor necrosis factor genes and susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high incidence region of North China. Chin Med J (Engl) 118(22):1870–1878
Ivansson EL, Magnusson JJ, Magnusson PK, Erlich HA, Gyllensten UB (2008) MHC loci affecting cervical cancer risk: distinguishing the effects of HLA-DQB1 and non-HLA genes TNF, LTA, TAP1 and TAP2. Genes Immun 9(7):613–623
Juszczynski P, Kalinka E, Bienvenu J, Woszczek G, Borowiec M, Robak T, Kowalski M, Lech-Maranda E, Baseggio L, Coiffier B, Salles G, Warzocha K (2002) Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome. Blood 100(8):3037–3040
Kadar K, Kovacs M, Karadi I, Melegh B, Pocsai Z, Mikala G, Tordai A, Szilagyi A, Adany R, Fust G, Varkonyi J (2008) Polymorphisms of TNF-alpha and LT-alpha genes in multiple myeloma. Leuk Res 32(10):1499–1504
Kamali-Sarvestani E, Merat A, Talei AR (2005) Polymorphism in the genes of alpha and beta tumor necrosis factors (TNF-alpha and TNF-beta) and gamma interferon (IFN-gamma) among Iranian women with breast cancer. Cancer Lett 223(1):113–119
Kano R (2004) Cytokine production and dermatophytosis. Nihon Ishinkin Gakkai Zasshi 45(3):131–136
Karakus N, Kara N, Ulusoy AN, Ozaslan C, Bek Y (2011) Tumor necrosis factor alpha and beta and interferon gamma gene polymorphisms in Turkish breast cancer patients. DNA Cell Biol 30(6):371–377
Kieszko R, Krawczyk P, Chocholska S, Dmoszynska A, Milanowski J (2010) TNF-alpha and TNF-beta gene polymorphisms in Polish patients with sarcoidosis. Connection with the susceptibility and prognosis. Sarcoidosis Vasc Diffuse Lung Dis 27(2):131–137
Kohaar I, Tiwari P, Kumar R, Nasare V, Thakur N, Das BC, Bharadwaj M (2009) Association of single nucleotide polymorphisms (SNPs) in TNF–LTA locus with breast cancer risk in Indian population. Breast Cancer Res Treat 114(2):347–355
Kronik N, Kogan Y, Elishmereni M, Halevi-Tobias K, Vuk-Pavlovic S, Agur Z (2010) Predicting outcomes of prostate cancer immunotherapy by personalized mathematical models. PLoS ONE 5(12):e15482
Lee SG, Kim B, Yook JH, Oh ST, Lee I, Song K (2004) TNF/LTA polymorphisms and risk for gastric cancer/duodenal ulcer in the Korean population. Cytokine 28(2):75–82
Lee KM, Park SK, Hamajima N, Tajima K, Yoo KY, Shin A, Noh DY, Ahn SH, Hirvonen A, Kang D (2005) Genetic polymorphisms of TGF-beta1 & TNF-beta and breast cancer risk. Breast Cancer Res Treat 90(2):149–155
Li C, Xia B, Yang Y, Li J, Xia HH (2005) TNF gene polymorphisms and Helicobacter pylori infection in gastric carcinogenesis in Chinese population. Am J Gastroenterol 100(2):290–294
Mroz P, Szokalska A, Wu MX, Hamblin MR (2010) Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response. PLoS ONE 5(12):e15194
Nonomura N, Tokizane T, Nakayama M, Inoue H, Nishimura K, Muramatsu M, Okuyama A (2006) Possible correlation between polymorphism in the tumor necrosis factor-beta gene and the clinicopathological features of bladder cancer in Japanese patients. Int J Urol 13(7):971–976
Onishi T, Ohishi Y, Goto H, Asano K, Makino H, Hatano T, Tomita M, Abe K, Imagawa K, Kinoshita M, Fukui T (1998) Study on the relationship between tumour necrosis factor gene polymorphism and prognosis in the patients with renal cell carcinoma. Nihon Hinyokika Gakkai Zasshi 89(3):413–420
Ovsyannikova IG, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA (2010) Extended LTA, TNF, LST1 and HLA gene haplotypes and their association with rubella vaccine-induced immunity. PLoS ONE 5(7):e11806
Park KS, Mok JW, Ko HE, Tokunaga K, Lee MH (2002) Polymorphisms of tumour necrosis factors A and B in breast cancer. Eur J Immunogenet 29(1):7–10
Partida-Rodriguez O, Torres J, Flores-Luna L, Camorlinga M, Nieves-Ramirez M, Lazcano E, Perez-Rodriguez M (2010) Polymorphisms in TNF and HSP-70 show a significant association with gastric cancer and duodenal ulcer. Int J Cancer 126(8):1861–1868
Pooja S, Francis A, Bid HK, Kumar S, Rajender S, Ramalingam K, Thangaraj K, Konwar R (2011) Role of ethnic variations in TNF-alpha and TNF-beta polymorphisms and risk of breast cancer in India. Breast Cancer Res Treat 126(3):739–747
Purdue MP, Sakoda LC, Graubard BI, Welch R, Chanock SJ, Sesterhenn IA, Rubertone MV, Erickson RL, McGlynn KA (2007) A case–control investigation of immune function gene polymorphisms and risk of testicular germ cell tumors. Cancer Epidemiol Biomarkers Prev 16(1):77–83
Seifart C, Plagens A, Dempfle A, Clostermann U, Vogelmeier C, von Wichert P, Seifart U (2005) TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer. Dis Markers 21(3):157–165
Shih CM, Lee YL, Chiou HL, Chen W, Chang GC, Chou MC, Lin LY (2006) Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer 52(1):15–20
Shimura T, Hagihara M, Takebe K, Munkhbat B, Odaka T, Kato H, Nagamachi Y, Tsuji K (1994) The study of tumor necrosis factor beta gene polymorphism in lung cancer patients. Cancer 73(4):1184–1188
Skeie GO, Pandey JP, Aarli JA, Gilhus NE (1999) TNFA and TNFB polymorphisms in myasthenia gravis. Arch Neurol 56(4):457–461
Skibola CF, Curry JD, Nieters A (2007) Genetic susceptibility to lymphoma. Haematologica 92(7):960–969
Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjose S, Hughes AM, Cerhan JR, Skibola DR, Purdue M, Kane E, Lan Q, Foretova L, Schenk M, Spinelli JJ, Slager SL, De Roos AJ, Smith MT, Roman E, Cozen W, Boffetta P, Kricker A, Zheng T, Lightfoot T, Cocco P, Benavente Y, Zhang Y, Hartge P, Linet MS, Becker N, Brennan P, Zhang L, Armstrong B, Smith A, Shiao R, Novak AJ, Maynadie M, Chanock SJ, Staines A, Holford TR, Holly EA, Rothman N, Wang SS (2010) Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol 171(3):267–276
Suzuki G, Cullings H, Fujiwara S, Matsuura S, Kishi T, Ohishi W, Akahoshi M, Hayashi T, Tahara E (2009) LTA 252GG and GA genotypes are associated with diffuse-type noncardia gastric cancer risk in the Japanese population. Helicobacter 14(6):571–579
Toth EK, Kocsis J, Madaras B, Biro A, Pocsai Z, Fust G, Blasko B, Karadi I, Adany R, Laki J (2007) The 8.1 ancestral MHC haplotype is strongly associated with colorectal cancer risk. Int J Cancer 121(8):1744–1748
Um JY, An NH, Kim HM (2003) TNF-alpha and TNF-beta gene polymorphisms in cerebral infarction. J Mol Neurosci 21(2):167–171
Warzocha K, Ribeiro P, Bienvenu J, Roy P, Charlot C, Rigal D, Coiffier B, Salles G (1998) Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin’s lymphoma outcome. Blood 91(10):3574–3581
Xiao H, Zhang K (2011) Genetic polymorphisms of tumor necrosis factor-alpha and lymphotoxin-alpha in Chinese patients with non-Hodgkin lymphoma. Ann Hematol 90(6):725–727
Yang JJ, Ko KP, Cho LY, Shin A, Gwack J, Chang SH, Shin HR, Yoo KY, Kang D, Park SK (2009) The role of TNF genetic variants and the interaction with cigarette smoking for gastric cancer risk: a nested case-control study. BMC Cancer 9:238
Yapijakis C, Serefoglou Z, Vylliotis A, Nkenke E, Derka S, Vassiliou S, Avgoustidis D, Neukam FW, Patsouris E, Vairaktaris E (2009) Association of polymorphisms in tumor necrosis factor alpha and beta genes with increased risk for oral cancer. Anticancer Res 29(6):2379–2386
Acknowledgments
This research was supported by the National Natural Science Foundation of China (No. 81202184).
Conflict of interest
The authors declare that there are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Yang, L., Feng, R., Liu, G. et al. TNF-β +252 A>G polymorphism and susceptibility to cancer. J Cancer Res Clin Oncol 139, 765–772 (2013). https://doi.org/10.1007/s00432-013-1384-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-013-1384-6